Search

everythinglearnresearchcommunity

for

Search:↓

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

COVID-19 may cause hair loss due to infection stress or treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Nursing care is crucial for safe and effective hair transplants.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Better diagnostic and treatment strategies are needed for acne keloidalis nuchae, especially in high-risk groups.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Higher levels of certain proteins may increase or decrease rosacea risk.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Stress and PCOS together may increase depression and anxiety-like behaviors.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.